Ashwani K. Singal MD

Dr. Singal is a Professor of Medicine at the University of Louisville School of Medicine and transplant hepatologist at the Trager Transplant Center in Louisville KY. In addition, he also directs the clinical trials program in the hepatology division at the University. 

With clinical and translational research interests in alcoholic and non-alcoholic fatty liver diseases, renal injury in cirrhosis, and porphyria, Dr. Singal’s research has been funded by the American College of Gastroenterology, National Institute of Health, and pharmaceutical industry. He has over 320 original peer reviewed articles in national / international journals and book chapters. He is an associate editor for Clinical Translational Gastroenterology, Digestive Liver Disease, and J Clinical Translational Hepatology (JCTH), and is on the editorial board of several journals including hepatology, liver transplantation, seminars in liver disease, clinical gastroenterology hepatology, and JHEP reports. 

Apart from reviewing research grants and scientific research abstracts for the AGA and AASLD, Dr. Singal is on the study section for the NIH and Multiple PI on the NIAAA funded UO1 Alcoholic Hepatitis Network in the US. He is lead author on both versions of practice guidelines for alcoholic liver disease (2018 and 2024), has co-authored guidelines on vascular disorders of the liver (2020), and guidelines on nutritional management of patients with cirrhosis (in press). Dr. Singal has been awarded the prestigious Edgar Achkar Visiting Professorship by the ACG, highly cited author award from JCTH, and international fellowship from National Academy of Medical Sciences in India. He is currently Chair of the Liver Biliary section of American Gastroenterology Association, Advisor on the Special Interest Group (SIG) Task Force for AASLD, Chair of the alcohol-associated liver disease (ALD) committee of CLD Foundation, and chaired the SIG on ALD for the AASLD (2020-2021).